Company JW Shinyak Corporation

A067290

KR7067290007

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Specialty & Advanced Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
1,799 ^KRW	+1.01%		+1.30%	-27.46%

Mar. 18	JW Shinyak Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	JW Shinyak Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

JW SHINYAK CORPORATION is a Korea-based company principally engaged in the manufacture and distribution of pharmaceuticals. The Companyâs main products portfolio consists of antibiotics, anesthetics, respiratory remedies, urology remedies, cardiovascular remedies, allergy remedies, digestive remedies, anti-inflammatory drugs, antivirals as well as acne remedies, among others. In addition, it also involves in the provision of cosmetics, such as creams, cleansers, toners, essences, lotions and others.

Number of employees: 231

KRW in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	102,710	100.0 %	104,235	100.0 %	+1.48%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	102,710	100.0 %	104,235	100.0 %	+1.48%

Managers	Title	Age	Since
Seung-Ho Baek CEO	Chief Executive Officer	62	17-02-15
Pil-Kyu Kim IND	Independent Dir/Board Member	65	21-02-07

Members of the board	Title	Age	Since
Seung-Ho Baek CEO	Chief Executive Officer	62	17-02-15
Pil-Kyu Kim IND	Independent Dir/Board Member	65	21-02-07
Myung-Chul Lee BRD	Director/Board Member	75	-
Chul-Woong Han BRD	Director/Board Member	49	17-02-15
Yong-Gwan Kim BRD	Director/Board Member	56	21-02-07
Am-Gu Kang BRD	Director/Board Member	-	18-03-21
Kyeong-Bok Kim BRD	Director/Board Member	59	-
Jung-Woon Wang BRD	Director/Board Member	57	-
Yeon-Seok Son BRD	Director/Board Member	55	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	50,834,469	35,817,492 ( 70.46 %)	140,665 ( 0.2767 %)	70.46 %

Name	Equities	%	Valuation
JW HOLDINGS CORPORATION 30.71 %	15,615,962	30.71 %	23 M ₩
RBC Global Asset Management (Asia) Ltd. 0.0471 %	23,955	0.0471 %	35 677 ₩
Seung Yong Im 0.0255 %	12,967	0.0255 %	19 312 ₩
Yong-Gwan Kim 0.0207 %	10,500	0.0207 %	15 638 ₩
DFA Australia Ltd. 0.001216 %	618	0.001216 %	920 ₩

JW SHINYAK Corp.

2477 Nambusunhwan-ro Seocho-gu

06725, Seoul

http://www.jw-shinyak.co.kr

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
JW SHINYAK CORPORATION	-27.46%	66.26M
MERCK KGAA	+5.31%	70.44B
KYOWA KIRIN CO. LTD.	+10.97%	8.94B
SK BIOPHARMACEUTICALS CO., LTD.	-16.83%	4.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+43.48%	4.5B
YUHAN CORPORATION	+3.20%	3.85B
BETTA PHARMACEUTICALS CO., LTD.	-21.36%	2.34B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-29.67%	2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+8.38%	1.96B
SUPERNUS PHARMACEUTICALS, INC.	+3.90%	1.65B

Specialty & Advanced Pharmaceuticals